Healthcare
Investing News
Market News
Technology
The Market Buzz
Merck Enters Definitive Agreement to Acquire Imago Biosciences
Merck (NYSE: MRK) and Imago Biosciences, Inc. (NASDAQ: IMGO) has reported entry into a definitive agreement where Merck through its subsidiary will acquire Imago for USD 36 per share...